Bernard E. Ilson

1.0k total citations
33 papers, 825 citations indexed

About

Bernard E. Ilson is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Bernard E. Ilson has authored 33 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Bernard E. Ilson's work include Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (5 papers) and Potassium and Related Disorders (4 papers). Bernard E. Ilson is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (5 papers) and Potassium and Related Disorders (4 papers). Bernard E. Ilson collaborates with scholars based in United States, United Kingdom and South Korea. Bernard E. Ilson's co-authors include Diane K. Jorkasky, Steven C. Boike, David M. Tenero, David E. Martin, Névine Zariffa, Randall T. Curnow, Martin I. Freed, Susan C. Brozena, David J. Kazierad and M. A. Pue and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Infectious Diseases and The American Journal of Cardiology.

In The Last Decade

Bernard E. Ilson

33 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard E. Ilson United States 17 360 204 115 112 105 33 825
Iris Rajman Switzerland 17 372 1.0× 221 1.1× 61 0.5× 169 1.5× 78 0.7× 31 885
Pertti J. Pentikäinen Finland 18 466 1.3× 126 0.6× 69 0.6× 173 1.5× 101 1.0× 32 937
David J. Kazierad United States 14 166 0.5× 192 0.9× 91 0.8× 108 1.0× 103 1.0× 27 560
Juliane Bolbrinker Germany 18 339 0.9× 118 0.6× 87 0.8× 181 1.6× 100 1.0× 52 814
A Breckenridge United Kingdom 17 242 0.7× 138 0.7× 87 0.8× 92 0.8× 326 3.1× 57 1.1k
Alan Jones United Kingdom 17 320 0.9× 272 1.3× 178 1.5× 239 2.1× 32 0.3× 36 928
John A. Opsahl United States 17 457 1.3× 129 0.6× 72 0.6× 197 1.8× 63 0.6× 48 1.1k
James J. Nawarskas United States 21 509 1.4× 111 0.5× 72 0.6× 249 2.2× 55 0.5× 65 1.1k
Francesco Fıcı Italy 16 532 1.5× 215 1.1× 101 0.9× 123 1.1× 20 0.2× 60 945
Kenneth L. Duchin United States 17 383 1.1× 113 0.6× 42 0.4× 60 0.5× 104 1.0× 43 1.0k

Countries citing papers authored by Bernard E. Ilson

Since Specialization
Citations

This map shows the geographic impact of Bernard E. Ilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard E. Ilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard E. Ilson more than expected).

Fields of papers citing papers by Bernard E. Ilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard E. Ilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard E. Ilson. The network helps show where Bernard E. Ilson may publish in the future.

Co-authorship network of co-authors of Bernard E. Ilson

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard E. Ilson. A scholar is included among the top collaborators of Bernard E. Ilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard E. Ilson. Bernard E. Ilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morganroth, Joel, et al.. (2004). Evaluation of vardenafil and sildenafil on cardiac repolarization. The American Journal of Cardiology. 93(11). 1378–1383. 56 indexed citations
2.
Topol, Eric J., J. Donald Easton, Pierre Amarenco, et al.. (2000). Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial. American Heart Journal. 139(6). 927–933. 52 indexed citations
3.
Kovacs, Steven J., David M. Tenero, David E. Martin, Bernard E. Ilson, & Diane K. Jorkasky. (1999). Pharmacokinetics and Protein Binding of Eprosartan in Hemodialysis‐Dependent Patients with End‐Stage Renal Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(5). 612–619. 14 indexed citations
4.
Freed, Martin I., et al.. (1999). Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone. Clinical Pharmacology & Therapeutics. 65(5). 473–482. 16 indexed citations
5.
Kazierad, David J., David E. Martin, Bernard E. Ilson, et al.. (1998). Eprosartan Does Not Affect the Pharmacodynamics of Warfarin. The Journal of Clinical Pharmacology. 38(7). 649–653. 10 indexed citations
6.
Martin, David E., Bernard E. Ilson, David M. Tenero, et al.. (1998). Pharmacokinetics and Protein Binding of Eprosartan in Healthy Volunteers and in Patients with Varying Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 38(2). 129–137. 31 indexed citations
7.
Martin, David E., et al.. (1998). A Dose Proportionality Study of Eprosartan in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 38(1). 34–39. 19 indexed citations
8.
Ilson, Bernard E., Steven C. Boike, David E. Martin, et al.. (1998). A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men*. Clinical Pharmacology & Therapeutics. 63(4). 471–481. 8 indexed citations
9.
Ilson, Bernard E., David E. Martin, Steven C. Boike, & Diane K. Jorkasky. (1998). The Effects of Eprosartan, an Angiotensin II AT1 Receptor Antagonist, on Uric Acid Excretion in Patients with Mild to Moderate Essential Hypertension. The Journal of Clinical Pharmacology. 38(5). 437–441. 20 indexed citations
10.
Tenero, David M., David E. Martin, Ann K. Miller, et al.. (1998). Effect of age and gender on the pharmacokinetics of eprosartan. British Journal of Clinical Pharmacology. 46(3). 267–270. 17 indexed citations
11.
Boike, Steven C., Bernard E. Ilson, Névine Zariffa, & Diane K. Jorkasky. (1997). Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. American Journal of Health-System Pharmacy. 54(10). 1172–1176. 52 indexed citations
12.
Kazierad, David J., David E. Martin, David M. Tenero, et al.. (1997). Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers*. Clinical Pharmacology & Therapeutics. 62(4). 417–425. 65 indexed citations
13.
Martin, David E., Debra Tompson, Steven C. Boike, et al.. (1997). Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers. British Journal of Clinical Pharmacology. 43(6). 661–664. 22 indexed citations
14.
Tenero, David M., et al.. (1996). Dose-Proportional Stereoselective Kinetics of Carvedilol in Patients with CHF. Clinical Pharmacology & Therapeutics. 59(2). 201–201. 6 indexed citations
15.
Freed, Martin I., Névine Zariffa, Gopal Krishna, et al.. (1994). Comparative Effects of Nabumetone, Sulindac, and Indomethacin on Urinary Prostaglandin Excretion and Platelet Function in Volunteers. The Journal of Clinical Pharmacology. 34(11). 1098–1108. 32 indexed citations
16.
Boike, Steven C., M. A. Pue, Martin I. Freed, et al.. (1994). Pharmacokinetics of Famciclovir in Subjects with Chronic Hepatic Disease. The Journal of Clinical Pharmacology. 34(12). 1199–1207. 28 indexed citations
17.
Boike, Steven C., M. A. Pue, Martin I. Freed, et al.. (1994). Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment. Clinical Pharmacology & Therapeutics. 55(4). 418–426. 43 indexed citations
18.
Jorkasky, Diane K., et al.. (1992). Fenoldopam Reverses Cyclosporine-Induced Renal Vasoconstriction in Kidney Transplant Recipients. American Journal of Kidney Diseases. 19(6). 567–572. 31 indexed citations
19.
Ilson, Bernard E., et al.. (1990). Metabolic Acidosis in a Diabetic Man. Hospital Practice. 25(10). 132–138. 1 indexed citations
20.
Ilson, Bernard E., et al.. (1989). EFFECT OF A NEW SYNTHETIC HEXAPEPTIDE TO SELECTIVELY STIMULATE GROWTH HORMONE RELEASE IN HEALTHY HUMAN SUBJECTS. The Journal of Clinical Endocrinology & Metabolism. 69(1). 212–214. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris Rajman Breakdown of academic impact, for papers by Pertti J. Pentikäinen Breakdown of academic impact, for papers by David J. Kazierad Breakdown of academic impact, for papers by Juliane Bolbrinker Breakdown of academic impact, for papers by A Breckenridge Breakdown of academic impact, for papers by Alan Jones Breakdown of academic impact, for papers by John A. Opsahl Breakdown of academic impact, for papers by James J. Nawarskas Breakdown of academic impact, for papers by Francesco Fıcı Breakdown of academic impact, for papers by Kenneth L. Duchin
Rankless by CCL
2026